Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 2/20 | 0.35 |
| ▸ | CDC25A | P30304 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | SOAT1 | P35610 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21065455 | 1.00 | PTPN1 (0.42) | PTPN1NR1H2NR1H3KCNH2GPR84 | |
| SCHEMBL2821603 | 0.98 | PTPN1 (0.40) | PTPN1NR1H2NR1H3KCNH2GPR84 | |
| SCHEMBL8780480 | 0.94 | PTPN1 (0.35) | PTPN1NR1H2NR1H3CES1CDC25A | |
| Phosphoric Acid SCHEMBL27784283 | 0.92 | CETP (0.39) | PTPN1NR1H2NR1H3 | |
| SCHEMBL9175519 | 0.88 | SHMT2 (0.34) | PTPN1CES1LMNATSHRL3MBTL1 | |
| SCHEMBL4764684 | 0.81 | SHMT2 (0.39) | CES1LMNATSHRTDP1L3MBTL1 | |
| SCHEMBL9361210 | 0.81 | EPHX2 (0.37) | LMNATDP1L3MBTL1 | |
| SCHEMBL28246116 | 0.78 | KCNH2 (0.41) | KCNH2TDP1L3MBTL1LIPGSIGMAR1 | |
| SCHEMBL3014252 | 0.78 | ALDH1A1 (0.36) | CES1LMNATSHRTDP1L3MBTL1 | |
| SCHEMBL7913644 | 0.77 | TDP1 (0.39) | PTPN1NR1H2NR1H3TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230184759-A1 | IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2023-06-15 | — | — | US | claimed |
| EP-4126820-A1 | IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA | Consejo Superior De Investigaciones Científicas (ES) | 2023-02-08 | — | — | EP | claimed |
| WO-2021198064-A1 | IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2021-10-07 | — | — | WO | claimed |
| US-20260138981-A1 | DIHYDROFOLATE REDUCTASE INHIBITORS FOR ANTI-BIOTIC RESISTANT INFECTIONS | THE TRUSTEES OF PRINCETON UNIV (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4702981-A1 | TARGETED ANTIBACTERIAL TREATMENT | Københavns Universitet (DK) | 2026-03-04 | — | — | EP | disclosed |
| CN-120761536-A | Detection and application for detecting pseudomonas aeruginosa metabolite based on HPLC-MS/MS | 长沙市食品药品检验所 | 2025-10-10 | — | — | CN | disclosed |
| WO-2024077235-A9 | DIHYDROFOLATE REDUCTASE INHIBITORS FOR ANTI-BIOTIC RESISTANT INFECTIONS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024077235-A2 | DIHYDROFOLATE REDUCTASE INHIBITORS FOR ANTI-BIOTIC RESISTANT INFECTIONS | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2024-04-11 | — | — | WO | disclosed |
| US-20230184759-A1 | IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (ES) | 2023-06-15 | — | — | US | disclosed |
| US-11596626-B2 | Compound for use against pathogenic Neisseria and Haemophilus species and Moraxella catarrhalis | Universität Konstanz (DE) | 2023-03-07 | — | — | US | disclosed |
| EP-4126820-A1 | IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA | Consejo Superior De Investigaciones Científicas (ES) | 2023-02-08 | — | — | EP | disclosed |
| EP-3475260-A1 | COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR | Universität Konstanz (DE) | 2019-05-01 | — | — | EP | disclosed |
| EP-2997382-B1 | ALKYL QUINOLONES AS BIOMARKERS OF PSEUDOMONAS AERUGINOSA INFECTION AND USES THEREOF | UNIV NOTTINGHAM (GB) | 2018-07-11 | — | — | EP | disclosed |
| CN-107613967-A | Host Defense Protein (HDP) mimetics for preventing and/or treating inflammatory diseases of the gastrointestinal tract | 创新制药公司 | 2018-01-19 | — | — | CN | disclosed |
| WO-2017220205-A1 | COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR | Universität Konstanz (DE) | 2017-12-28 | — | — | WO | disclosed |
| EP-3260445-A1 | COMPOUNDS FOR USE AS AN ANTI-BACTERIAL OR ANTI-FUNGAL AGENT AND AS A ZINC SENSOR | Universität Konstanz (DE) | 2017-12-27 | — | — | EP | disclosed |
| EP-2598651-A1 | METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION | Sanofi-Aventis Deutschland GmbH (DE) | 2013-06-05 | — | — | EP | disclosed |
| US-20130123360-A1 | METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2013-05-16 | — | — | US | disclosed |
| WO-2012013621-A1 | METHODS AND USES RELATING TO THE IDENTIFICATION OF COMPOUND ASSOCIATED WITH BACTERIAL INFECTION | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2012-02-02 | — | — | WO | disclosed |
| EP-2412819-A1 | Methods and uses relating to the identification of compound associated with bacterial infection | Sanofi-Aventis Deutschland GmbH (DE) | 2012-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11596626-B2 | Compound for use against pathogenic Neisseria and Haemophilus species and Moraxella catarrhalis | MLEC, MPO, B3GNT2 | PTPN1 3261/4885NR1H2 1226/4885NR1H3 1263/4885 |
| US-20230184759-A1 | IN VITRO METHOD FOR DETECTION OF INFECTIONS CAUSED BY PSEUDOMONAS AERUGINOSA | QSOX1, QARS1, CD47 | PTPN1 22/4885NR1H2 2554/4885NR1H3 2344/4885 |
| US-20260138981-A1 | DIHYDROFOLATE REDUCTASE INHIBITORS FOR ANTI-BIOTIC RESISTANT INFECTIONS | DHFR, CBR1, DHRS9 | PTPN1 2329/4885NR1H2 175/4885NR1H3 221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.